329 related articles for article (PubMed ID: 17243056)
21. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
22. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Sorror ML; Maris MB; Storer B; Sandmaier BM; Diaconescu R; Flowers C; Maloney DG; Storb R
Blood; 2004 Aug; 104(4):961-8. PubMed ID: 15113759
[TBL] [Abstract][Full Text] [Related]
23. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
[TBL] [Abstract][Full Text] [Related]
24. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
[TBL] [Abstract][Full Text] [Related]
25. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation.
Thursky K; Byrnes G; Grigg A; Szer J; Slavin M
Bone Marrow Transplant; 2004 Jul; 34(2):115-21. PubMed ID: 15156166
[TBL] [Abstract][Full Text] [Related]
27. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
28. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Parikh CR; Schrier RW; Storer B; Diaconescu R; Sorror ML; Maris MB; Maloney DG; McSweeney P; Storb R; Sandmaier BM
Am J Kidney Dis; 2005 Mar; 45(3):502-9. PubMed ID: 15754272
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
[TBL] [Abstract][Full Text] [Related]
30. Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation.
Fann JR; Hubbard RA; Alfano CM; Roth-Roemer S; Katon WJ; Syrjala KL
J Clin Oncol; 2011 Mar; 29(7):895-901. PubMed ID: 21263081
[TBL] [Abstract][Full Text] [Related]
31. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
32. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Lestrade PP; Bentvelsen RG; Schauwvlieghe AFAD; Schalekamp S; van der Velden WJFM; Kuiper EJ; van Paassen J; van der Hoven B; van der Lee HA; Melchers WJG; de Haan AF; van der Hoeven HL; Rijnders BJA; van der Beek MT; Verweij PE
Clin Infect Dis; 2019 Apr; 68(9):1463-1471. PubMed ID: 30307492
[TBL] [Abstract][Full Text] [Related]
33. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Baddley JW; Andes DR; Marr KA; Kauffman CA; Kontoyiannis DP; Ito JI; Schuster MG; Brizendine KD; Patterson TF; Lyon GM; Boeckh M; Oster RA; Chiller T; Pappas PG
Med Mycol; 2013 Feb; 51(2):128-35. PubMed ID: 22680976
[TBL] [Abstract][Full Text] [Related]
34. [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy].
Rácil Z; Mayer J; Kocmanová I; Wagnerová B; Winterová J; Folber F; Lengerová M; Moulis M; Zácková D; Smardová L; Janíková A; Navrátil M; Dvoráková D; Vorlícek J
Vnitr Lek; 2008 Feb; 54(2):157-68. PubMed ID: 23687707
[TBL] [Abstract][Full Text] [Related]
35. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality.
Vandewoude K; Blot S; Benoit D; Depuydt P; Vogelaers D; Colardyn F
Acta Clin Belg; 2004; 59(5):251-7. PubMed ID: 15641394
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
37. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Diaconescu R; Flowers CR; Storer B; Sorror ML; Maris MB; Maloney DG; Sandmaier BM; Storb R
Blood; 2004 Sep; 104(5):1550-8. PubMed ID: 15150081
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
[TBL] [Abstract][Full Text] [Related]
39. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with overall and attributable mortality in invasive aspergillosis.
Nivoix Y; Velten M; Letscher-Bru V; Moghaddam A; Natarajan-Amé S; Fohrer C; Lioure B; Bilger K; Lutun P; Marcellin L; Launoy A; Freys G; Bergerat JP; Herbrecht R
Clin Infect Dis; 2008 Nov; 47(9):1176-84. PubMed ID: 18808352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]